* Cerus Corp reported a quarterly adjusted loss of 2 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -3 cents. The mean expectation of six analysts for the quarter was for a loss of 3 cents per share.
* Revenue rose 15.7% to $46.02 million from a year ago; analysts expected $47.34 million.
* Cerus Corp's reported EPS for the quarter was a loss of 2 cents.
* The company reported a quarterly loss of $2.93 million.
* Cerus Corp shares had fallen by 2.3% this quarter and lost 21.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 5.3% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Cerus Corp is $4.00 This summary was machine generated from LSEG data October 31 at 02:37 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.03 -0.02 Beat
Jun. 30 2024 -0.04 -0.03 Beat
Mar. 31 2024 -0.05 -0.05 Met
Dec. 31 2023 -0.02 -0.01 Beat
Comments